D2R et AReNA put RNA experts forward at the 92nd ACFAS Congress
May 8, 2025
On May 5, 2025, the Future of Genomic Medicine and its Implications in the Context of RNA Therapies symposium, jointly organized by D2R and AReNA, took place as part of the 92nd ACFAS congress in Montreal.
Three panels, made up of RNA experts and leaders from the Life Sciences and Health Technologies (LSHT) sector, highlighted recent advances and the future of RNA therapies, while addressing the challenges facing the development and commercialization of these therapies. The need for greater collaboration between researchers, healthcare professionals and industry was one of the points to emerge from the discussions.
